Introduction: Surfactant replacement therapy is one of the best studied therapies in neonates. It has been shown in numerous clinical trials to be successful in ameliorating RDS. These trials have examined the effects of surfactant preparations delivered through the endo tracheal tube either within minutes of birth(prophylactic treatment) or after the symptoms and signs of RDS are present (selective or “rescue” treatment). Methodology: Details regarding maternal risk factors were collected by detailed history taking and the medical records with them. The infants in the sample were followed throughout their stay in the SNCU and postnatal wards, up until hospital discharge. Data were collected from infants and mothers medical records and supplemented with additional information collected at discharge using a structured form covering the variables of interest. Variables relating to the mothers and their infants were analyzed Results: Regarding respiratory morbidities, 34 neonates presented with respiratory distress secondary to pneumonia which accounts for 2%. 2 of the neonates presented as TTNB which accounts for about 2%. 62 neonates didn’t have any respiratory distress which accounts for about6 2%. Conclusion: Birth asphyxia constitutes the second most morbidity with 41 neonates affected which constitute about 41%. A large number of the infants in this study had respiratory distress 34%, followed by Pneumonia and TTN.

Keywords: Birth Asphyxia; Pneumonia; RDS.